Moreover, Eupafolin treatment significantly increased the apoptotic ratio of breast cancer cells (Fig. 2D), and as the expression of cleaved caspase-3 and Bax increased, the expression of Bcl-2 decreased (Fig. 2E). This evidence concerns the gene BAX and breast carcinoma.